Skip to content
OpenCapital
Get started

Medtronic MDT Derivative Assets and Liabilities, Net, Collateral, Obligation to Return Cash

Other financials

Income statement

See full
Revenue$9.8B+9.9%
Gross profit$6.4B+10.9%
Operating income$1.9B+30.4%
Net income$1.2B+17.8%
EPS (diluted)$0.97+18.3%

Balance sheet

See full
Cash & equivalents$1.9B-12.1%
Total debt$29.2B-1.6%
Total equity$49.5B+3.0%
Total assets$93.0B+1.5%

Cash flow

See full
Operating cash flow$2.6B+1.8%
CapEx$488.0M+6.3%
Free cash flow$2.1B+0.8%

Valuation

See full
Market cap$101.86B-3.8%
Enterprise value$129.12B-3.2%
P/E21.2×-1.5×
P/S2.8×-0.4×

Profitability

See full
Gross margin65%-0.3pp
Operating margin17.8%0.0pp
Net margin13.2%-0.7pp

Returns & leverage

See full
Return on equity9.8%+0.4pp
Debt / equity0.6×0.0×
Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept mdt:DerivativeAssetsandLiabilitiesNetCollateralObligationtoReturnCash.

The official record: Medtronic’s 10-Q, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medtronic's derivative assets and liabilities, net, collateral, obligation to return cash.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medtronic's derivative assets and liabilities, net, collateral, obligation to return cash?
Medtronic (MDT) reported derivative assets and liabilities, net, collateral, obligation to return cash of -$115M in Q4 2025.
How has Medtronic's derivative assets and liabilities, net, collateral, obligation to return cash changed year-over-year?
Medtronic's derivative assets and liabilities, net, collateral, obligation to return cash decreased by 142.4% year-over-year, from $271M to -$115M.
What is the long-term trend for Medtronic's derivative assets and liabilities, net, collateral, obligation to return cash?
Over 4 years (2021 to 2025), Medtronic's derivative assets and liabilities, net, collateral, obligation to return cash has grown at a 28.4% compound annual growth rate (CAGR), from -$46M to -$125M.